Diagnomics is an early stage Next Generation Sequencing (NGS) and genomics company based in San Diego. It's seed capital investor is Genautica.
The company's founders are a team of eminently qualified scientists who were also the founders of PGI Korea - an NGS non-profit entity that sequenced the 1st woman, the 1st Korean and 2nd Asian. PGI also has an exclusive collaboration agreement with BGI Shenzhen, China - the leading genome center in the world.
Diagnomics' objective is to set-up NGS genome centers, first in San Diego, CA then worldwide.